NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS was reported 317 times

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL ANASTOMOTIC HAEMORRHAGE 1 0.0833
1 SWOLLEN JOINT COUNT ABNORMAL 1 0.0526
2 BIOPSY ENDOMETRIUM ABNORMAL 1 0.0385
3 PERTHES DISEASE 1 0.0278
4 HEMIATAXIA 1 0.0263
5 GRIP STRENGTH 5 0.0218
6 LACTATION PUERPERAL INCREASED 1 0.0172
7 NEUROCRYPTOCOCCOSIS 1 0.0161
8 ACQUIRED PORPHYRIA 1 0.0141
9 ADMINISTRATION SITE ODOUR 1 0.0132
10 MANUFACTURING PRODUCT STORAGE ISSUE 1 0.0119
11 AMINO ACID LEVEL ABNORMAL 1 0.0103
12 OTOSCLEROSIS 1 0.0100
13 SWOLLEN JOINT COUNT 2 0.0080
14 SOLAR URTICARIA 1 0.0079
15 PHLEBOTHROMBOSIS 1 0.0078
16 GINGIVAL ABSCESS 5 0.0066
17 AMINO ACID LEVEL DECREASED 2 0.0059
18 INJECTION SITE ECZEMA 1 0.0052
19 FAILED INDUCTION OF LABOUR 1 0.0052
20 MICROVASCULAR CORONARY ARTERY DISEASE 1 0.0047
21 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
22 MENSTRUAL CLOTS 1 0.0042
23 CSF PRESSURE INCREASED 1 0.0038
24 SCIATIC NERVE INJURY 3 0.0036
25 INJECTION SITE HYPERTROPHY 1 0.0031
26 SOCIAL ANXIETY DISORDER 2 0.0030
27 MENSTRUATION NORMAL 1 0.0030
28 LUPUS VULGARIS 3 0.0024
29 THREATENED LABOUR 1 0.0023
30 NEUROMA 1 0.0022
31 FACET JOINT SYNDROME 7 0.0021
32 DEEP VEIN THROMBOSIS POSTOPERATIVE 4 0.0020
33 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
34 ENZYME ABNORMALITY 1 0.0019
35 BLOOD GROWTH HORMONE INCREASED 1 0.0018
36 DISLOCATION OF VERTEBRA 4 0.0018
37 RETINITIS 3 0.0017
38 THALAMIC INFARCTION 1 0.0017
39 X-RAY ABNORMAL 3 0.0017
40 FASCIITIS 1 0.0015
41 PRECANCEROUS CONDITION 1 0.0015
42 PORPHYRIA ACUTE 2 0.0014
43 INJECTION SITE BURNING 1 0.0013
44 SWOLLEN JOINT COUNT INCREASED 4 0.0013
45 OESOPHAGEAL RUPTURE 1 0.0012
46 CORONARY ARTERY DISSECTION 1 0.0012
47 VERTIGO POSITIONAL 2 0.0011
48 INFUSION SITE DISCHARGE 2 0.0011
49 BONE EROSION 4 0.0011
50 VASOSPASM 1 0.0011
51 BIOPSY 1 0.0011
52 SOLAR LENTIGO 1 0.0011
53 MESENTERIC VEIN THROMBOSIS 1 0.0010
54 ALLERGY TO ANIMAL 1 0.0009
55 NAIL GROWTH ABNORMAL 1 0.0009
56 VANISHING BILE DUCT SYNDROME 1 0.0009
57 MENOPAUSAL SYMPTOMS 2 0.0009
58 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
59 EYELID SKIN DRYNESS 1 0.0008
60 BURSITIS 10 0.0008
61 TOOTH EROSION 1 0.0008
62 DUODENAL ULCER PERFORATION 6 0.0008
63 GRIP STRENGTH DECREASED 7 0.0008
64 BAND SENSATION 1 0.0008
65 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
66 EXOSTOSIS 7 0.0008
67 VULVOVAGINAL CANDIDIASIS 1 0.0007
68 PERIPHERAL VENOUS DISEASE 3 0.0007
69 CLUSTER HEADACHE 1 0.0007
70 CARDIOVERSION 1 0.0007
71 INTERMENSTRUAL BLEEDING 4 0.0007
72 MYELITIS TRANSVERSE 1 0.0007
73 APPENDIX DISORDER 1 0.0007
74 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
75 RHEUMATOID FACTOR POSITIVE 4 0.0007
76 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
77 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
78 HELICOBACTER INFECTION 7 0.0007
79 INFUSION SITE INDURATION 1 0.0007
80 RHEUMATIC FEVER 3 0.0007
81 TRANSCRIPTION MEDICATION ERROR 1 0.0006
82 OPHTHALMOPLEGIA 1 0.0006
83 HYPERCHOLESTEROLAEMIA 6 0.0006
84 VULVOVAGINAL DRYNESS 2 0.0006
85 BREAST CANCER STAGE III 4 0.0006
86 ACUTE SINUSITIS 1 0.0006
87 FOLLICULITIS 6 0.0006
88 MACULOPATHY 2 0.0006
89 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4 0.0006
90 SOFT TISSUE INFECTION 1 0.0005
91 FOOT DEFORMITY 6 0.0005
92 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
93 CYSTOID MACULAR OEDEMA 1 0.0005
94 BODY TEMPERATURE DECREASED 5 0.0005
95 CORONARY ARTERY THROMBOSIS 1 0.0005
96 REBOUND ECZEMA 1 0.0005
97 DEMYELINATION 2 0.0005
98 CHOLANGITIS SCLEROSING 1 0.0005
99 HYPERPARATHYROIDISM 1 0.0005
100 PURULENT DISCHARGE 2 0.0005
101 FACIAL PALSY 1 0.0005
102 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
103 PERIODONTITIS 1 0.0005
104 OLIGOMENORRHOEA 1 0.0005
105 HAND DEFORMITY 6 0.0005
106 MELANOCYTIC NAEVUS 2 0.0005
107 WALKING AID USER 3 0.0005
108 INFECTIOUS MONONUCLEOSIS 1 0.0004
109 METASTASES TO MENINGES 1 0.0004
110 REACTION TO EXCIPIENT 1 0.0004
111 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
112 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
113 VULVOVAGINAL PAIN 2 0.0004
114 HYPOKINESIA 6 0.0004
115 AUTOIMMUNE DISORDER 4 0.0004
116 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
117 INJECTION SITE ABSCESS 1 0.0004
118 DERMATOMYOSITIS 1 0.0004
119 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
120 PREGNANCY ON ORAL CONTRACEPTIVE 1 0.0004
121 SCIATICA 6 0.0004
122 BREAST SWELLING 1 0.0004
123 PHARYNGITIS STREPTOCOCCAL 4 0.0004
124 LARGE INTESTINAL ULCER 1 0.0004
125 CLUMSINESS 1 0.0004
126 PLEURITIC PAIN 1 0.0004
127 MUSCLE INJURY 3 0.0004
128 INFUSION SITE ERYTHEMA 3 0.0004
129 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
130 BILIARY COLIC 1 0.0003
131 INFUSION SITE REACTION 1 0.0003
132 HEAVY MENSTRUAL BLEEDING 3 0.0003
133 LIP DRY 3 0.0003
134 DYSAESTHESIA 1 0.0003
135 CHEST X-RAY ABNORMAL 1 0.0003
136 HEPATIC CIRRHOSIS 6 0.0003
137 INFUSION SITE SWELLING 2 0.0003
138 INFUSION SITE PRURITUS 1 0.0003
139 GLOSSODYNIA 7 0.0003
140 LYMPHOCYTE COUNT INCREASED 1 0.0003
141 BRADYPHRENIA 2 0.0003
142 INFUSION SITE HAEMORRHAGE 1 0.0003
143 EXPOSURE DURING BREAST FEEDING 1 0.0003
144 JOINT RANGE OF MOTION DECREASED 4 0.0003
145 WRONG PRODUCT ADMINISTERED 2 0.0003
146 HEPATIC FIBROSIS 1 0.0003
147 HYPOPNOEA 1 0.0003
148 AUTOIMMUNE HEPATITIS 2 0.0003
149 APPLICATION SITE REACTION 2 0.0003
150 WOUND INFECTION 3 0.0003
151 INTENTIONAL UNDERDOSE 2 0.0003
152 NEURODERMATITIS 1 0.0003
153 THROAT CLEARING 1 0.0003
154 CHRONIC SINUSITIS 1 0.0003
155 EAR INFECTION 7 0.0003
156 ARTERIOSPASM CORONARY 1 0.0002
157 PRODUCT ADMINISTRATION ERROR 5 0.0002
158 FIBROMYALGIA 6 0.0002
159 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
160 HYPERSOMNIA 7 0.0002
161 PEMPHIGUS 3 0.0002
162 PERICARDITIS 4 0.0002
163 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
164 LUNG NEOPLASM 1 0.0002
165 INFUSION SITE PAIN 3 0.0002
166 CARDIAC OPERATION 2 0.0002
167 RHINITIS ALLERGIC 1 0.0002
168 FREQUENT BOWEL MOVEMENTS 6 0.0002
169 SYNOVITIS 4 0.0002
170 PAPILLOEDEMA 1 0.0002
171 URINE ABNORMALITY 1 0.0002
172 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
173 YELLOW SKIN 1 0.0002
174 FLANK PAIN 2 0.0002
175 PULMONARY FIBROSIS 4 0.0002
176 LOWER LIMB FRACTURE 4 0.0002
177 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
178 INJECTION SITE INFLAMMATION 1 0.0002
179 CORONARY ARTERY STENOSIS 1 0.0002
180 ABDOMINAL PAIN LOWER 5 0.0002
181 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
182 CEREBRAL ISCHAEMIA 1 0.0002
183 RENAL PAIN 2 0.0002
184 OBESITY 3 0.0002
185 PHARYNGOLARYNGEAL PAIN 1 0.0002
186 BREAST PAIN 2 0.0002
187 FOOD POISONING 1 0.0002
188 IRRITABLE BOWEL SYNDROME 4 0.0002
189 INJECTION SITE DISCHARGE 1 0.0002
190 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
191 IMPAIRED HEALING 6 0.0002
192 DEAFNESS UNILATERAL 1 0.0002
193 CYSTIC FIBROSIS 1 0.0002
194 STREPTOCOCCAL INFECTION 1 0.0002
195 INTRACRANIAL PRESSURE INCREASED 1 0.0002
196 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
197 CORONARY ARTERY BYPASS 1 0.0002
198 PRODUCT LABEL CONFUSION 1 0.0002
199 HYPERTRIGLYCERIDAEMIA 1 0.0002
200 DECREASED INTEREST 1 0.0002
201 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
202 PRODUCT PRESCRIBING ERROR 4 0.0002
203 BLOOD POTASSIUM DECREASED 5 0.0002
204 HEPATITIS CHOLESTATIC 1 0.0002
205 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
206 PIGMENTATION DISORDER 1 0.0002
207 INFUSION SITE EXTRAVASATION 1 0.0002
208 MUSCLE ATROPHY 2 0.0002
209 DIPLOPIA 4 0.0002
210 MUSCULOSKELETAL PAIN 8 0.0002
211 CORONAVIRUS INFECTION 1 0.0002
212 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
213 DYSMENORRHOEA 2 0.0002
214 PREGNANCY 3 0.0001
215 MALIGNANT MELANOMA 2 0.0001
216 POST-TRAUMATIC STRESS DISORDER 1 0.0001
217 DISCOMFORT 9 0.0001
218 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
219 MOOD ALTERED 4 0.0001
220 EYE MOVEMENT DISORDER 1 0.0001
221 DROOLING 1 0.0001
222 ENCEPHALITIS 1 0.0001
223 LARGE INTESTINE PERFORATION 1 0.0001
224 KNEE ARTHROPLASTY 3 0.0001
225 HEART RATE DECREASED 5 0.0001
226 SEASONAL ALLERGY 2 0.0001
227 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
228 INTENTIONAL DOSE OMISSION 4 0.0001
229 PANIC REACTION 1 0.0001
230 DERMATITIS BULLOUS 1 0.0001
231 NEEDLE ISSUE 4 0.0001
232 MAJOR DEPRESSION 1 0.0001
233 CEREBRAL DISORDER 1 0.0001
234 ILL-DEFINED DISORDER 8 0.0001
235 PROCEDURAL COMPLICATION 1 0.0001
236 MUSCULOSKELETAL CHEST PAIN 2 0.0001
237 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
238 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
239 SENSORY LOSS 1 0.0001
240 NIGHT SWEATS 4 0.0001
241 MYASTHENIA GRAVIS 1 0.0001
242 SUBSTANCE ABUSE 1 0.0001
243 LIVER INJURY 3 0.0001
244 LETHARGY 7 0.0001
245 OSTEOPOROSIS 5 0.0001
246 INFUSION RELATED REACTION 8 0.0001
247 HEPATIC ENZYME INCREASED 8 0.0001
248 SINUSITIS 12 0.0001
249 VITAMIN D DECREASED 1 0.0001
250 INFLAMMATION 6 0.0001
251 MUSCULOSKELETAL DISCOMFORT 2 0.0001
252 HYSTERECTOMY 1 0.0001
253 DELIRIUM 4 0.0001
254 NAIL DISORDER 1 0.0001
255 CONTUSION 11 0.0001
256 FEELING HOT 7 0.0001
257 AMENORRHOEA 2 0.0001
258 SPINAL OSTEOARTHRITIS 1 0.0001
259 DERMATITIS ATOPIC 6 0.0001
260 PRODUCT COMMUNICATION ISSUE 1 0.0001
261 PURPURA 1 0.0001
262 MENSTRUATION IRREGULAR 3 0.0001
263 THIRST 2 0.0001
264 OROPHARYNGEAL DISCOMFORT 1 0.0001
265 OPTIC NEURITIS 1 0.0001
266 RESTLESS LEGS SYNDROME 2 0.0001
267 OVARIAN CANCER 1 0.0001
268 UROSEPSIS 1 0.0001
269 PRODUCT DISTRIBUTION ISSUE 1 0.0001
270 PERSONALITY CHANGE 1 0.0001
271 WOUND 3 0.0001
272 BLOOD CHOLESTEROL INCREASED 5 0.0001
273 DIARRHOEA HAEMORRHAGIC 1 0.0001
274 SPINAL DISORDER 1 0.0001
275 PRODUCTIVE COUGH 5 0.0001
276 SEROTONIN SYNDROME 2 0.0001
277 HERNIA 2 0.0001
278 PHARYNGEAL SWELLING 1 0.0001
279 INFLAMMATORY BOWEL DISEASE 1 0.0001
280 THERAPY CHANGE 1 0.0001
281 LABORATORY TEST ABNORMAL 3 0.0001
282 KNEE OPERATION 1 0.0001
283 DYSPEPSIA 10 0.0001
284 EMBEDDED DEVICE 1 0.0001
285 GASTROINTESTINAL DISORDER 9 0.0001
286 OVARIAN CYST 1 0.0001
287 INJURY 7 0.0001
288 VAGINAL DISCHARGE 1 0.0001
289 TOOTH ABSCESS 1 0.0001
290 EMOTIONAL DISORDER 3 0.0001
291 TENDERNESS 1 0.0001
292 UNINTENDED PREGNANCY 1 0.0001
293 ROAD TRAFFIC ACCIDENT 4 0.0001
294 INJECTION SITE DISCOMFORT 1 0.0001
295 OSTEOARTHRITIS 4 0.0001
296 MIGRAINE 9 0.0001
297 MOOD SWINGS 3 0.0001
298 LIVER FUNCTION TEST INCREASED 2 0.0001
299 RECTAL HAEMORRHAGE 4 0.0001
300 HOT FLUSH 7 0.0001
301 DISTURBANCE IN ATTENTION 5 0.0001
302 ACNE 7 0.0001
303 MENSTRUATION DELAYED 1 0.0001
304 BIPOLAR DISORDER 1 0.0001
305 DENTAL CARIES 1 0.0001
306 HYPERTENSIVE CRISIS 1 0.0001
307 COLITIS ULCERATIVE 4 0.0001
308 SKIN INFECTION 1 0.0001
309 TYPE 2 DIABETES MELLITUS 3 0.0001
310 INTESTINAL PERFORATION 1 0.0001
311 OCULAR DISCOMFORT 1 0.0001
312 EYE INFECTION 1 0.0001
313 STATUS EPILEPTICUS 1 0.0001
314 HEART RATE IRREGULAR 2 0.0001
315 DERMATITIS CONTACT 1 0.0001
316 PRODUCT SUBSTITUTION ISSUE 5 0.0001
317 DRY MOUTH 7 0.0001
318 ABDOMINAL DISTENSION 9 0.0001
319 MADAROSIS 1 0.0001
320 COVID-19 PNEUMONIA 1 0.0001
321 WHEEZING 5 0.0001
322 DISEASE RECURRENCE 4 0.0001
323 MACULAR DEGENERATION 1 0.0001
324 INFECTION 12 0.0001
325 VERTIGO 5 0.0001
326 INJECTION SITE URTICARIA 2 0.0001
327 TENDON RUPTURE 1 0.0001
328 GENERALISED OEDEMA 1 0.0001
329 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
330 RHINORRHOEA 5 0.0001
331 MUSCLE SPASMS 14 0.0001
332 BEDRIDDEN 1 0.0001
333 ANKYLOSING SPONDYLITIS 1 0.0001
334 ABORTION SPONTANEOUS 3 0.0001
335 PSORIATIC ARTHROPATHY 3 0.0001
336 HYPOAESTHESIA 11 0.0001
337 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
338 ARTHROPATHY 4 0.0001
339 ORAL DISCOMFORT 1 0.0001
340 FEELING COLD 2 0.0001
341 COORDINATION ABNORMAL 1 0.0001
342 APHONIA 1 0.0001
343 RENAL IMPAIRMENT 6 0.0001
344 BLISTER 4 0.0001
345 IMPAIRED QUALITY OF LIFE 1 0.0001
346 VAGINAL HAEMORRHAGE 3 0.0001
347 APATHY 1 0.0001
348 GASTROENTERITIS 1 0.0001
349 ACUTE MYOCARDIAL INFARCTION 2 0.0001
350 LIVER DISORDER 3 0.0001
351 PREMATURE BABY 2 0.0001
352 APHASIA 2 0.0001
353 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
354 NEPHROLITHIASIS 3 0.0001
355 INSURANCE ISSUE 1 0.0001
356 HIP ARTHROPLASTY 1 0.0001
357 DEVICE RELATED INFECTION 1 0.0001
358 ANKLE FRACTURE 1 0.0001
359 SWELLING 6 0.0001
360 THERAPY PARTIAL RESPONDER 1 0.0001
361 BASAL CELL CARCINOMA 1 0.0001
362 PRODUCT USE COMPLAINT 1 0.0001
363 RESPIRATORY TRACT CONGESTION 1 0.0001
364 HALLUCINATION, AUDITORY 1 0.0001
365 AMNESIA 4 0.0001
366 LUNG DISORDER 3 0.0001
367 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
368 ABDOMINAL PAIN 14 0.0001
369 VIRAL INFECTION 2 0.0001
370 COAGULOPATHY 1 0.0001
371 INJECTION SITE PRURITUS 4 0.0001
372 URTICARIA 10 0.0001
373 EYE PRURITUS 2 0.0001
374 CANDIDA INFECTION 1 0.0001
375 ANGER 2 0.0001
376 HEMIPARESIS 1 0.0001
377 FLUID RETENTION 3 0.0001
378 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
379 METRORRHAGIA 1 0.0001
380 ABDOMINAL PAIN UPPER 12 0.0001
381 PARANOIA 1 0.0001
382 DEVICE DEFECTIVE 1 0.0001
383 ECZEMA 3 0.0001
384 SYRINGE ISSUE 1 0.0001
385 PANCREATITIS 3 0.0001
386 DEPRESSED MOOD 3 0.0001
387 LYMPHOCYTE COUNT DECREASED 1 0.0001
388 HEAD DISCOMFORT 1 0.0001
389 ISCHAEMIC STROKE 1 0.0001
390 BACK PAIN 13 0.0001
391 CONFUSIONAL STATE 9 0.0001
392 MOBILITY DECREASED 4 0.0001
393 OEDEMA 3 0.0001
394 LEUKOCYTOSIS 1 0.0001
395 PELVIC PAIN 1 0.0001
396 CRYING 2 0.0001
397 END STAGE RENAL DISEASE 1 0.0001
398 BRONCHITIS 4 0.0001
399 EYE SWELLING 2 0.0001
400 THINKING ABNORMAL 1 0.0001
401 DYSARTHRIA 2 0.0001
402 DYSPNOEA EXERTIONAL 2 0.0001
403 ASTHMA 6 0.0001
404 FLATULENCE 3 0.0001
405 COLITIS 2 0.0001
406 DEPRESSION 12 0.0001
407 SLEEP APNOEA SYNDROME 1 0.0001
408 INCREASED APPETITE 1 0.0001
409 INJECTION SITE SWELLING 4 0.0001
410 CHOLESTASIS 1 0.0001
411 ACUTE RESPIRATORY FAILURE 1 0.0001
412 PRESCRIBED OVERDOSE 1 0.0001
413 HAEMORRHOIDS 1 0.0001
414 CHOKING 1 0.0001
415 SURGERY 3 0.0001
416 MENORRHAGIA 1 0.0001
417 ARTHRITIS 4 0.0001
418 PARAESTHESIA 8 0.0001
419 DISABILITY 1 0.0001
420 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
421 SINUS DISORDER 1 0.0001
422 DISORIENTATION 2 0.0001
423 CONSTIPATION 11 0.0001
424 COMPLICATION OF DEVICE INSERTION 1 0.0001
425 PRODUCT PHYSICAL ISSUE 1 0.0000
426 STOMATITIS 3 0.0000
427 HEADACHE 31 0.0000
428 TASTE DISORDER 1 0.0000
429 OEDEMA PERIPHERAL 6 0.0000
430 BODY TEMPERATURE INCREASED 1 0.0000
431 NASOPHARYNGITIS 9 0.0000
432 INSOMNIA 13 0.0000
433 HYPERSENSITIVITY 9 0.0000
434 PERITONITIS 1 0.0000
435 EXPOSURE DURING PREGNANCY 3 0.0000
436 TOOTH LOSS 1 0.0000
437 HALLUCINATION, VISUAL 1 0.0000
438 GAIT DISTURBANCE 9 0.0000
439 EATING DISORDER 1 0.0000
440 IMPAIRED WORK ABILITY 1 0.0000
441 HYPOACUSIS 2 0.0000
442 FATIGUE 36 0.0000
443 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
444 PRODUCT DOSE OMISSION 3 0.0000
445 PRODUCT DISPENSING ERROR 1 0.0000
446 PRODUCT PRESCRIBING ISSUE 1 0.0000
447 ANXIETY 13 0.0000
448 MUSCULOSKELETAL STIFFNESS 4 0.0000
449 COVID-19 8 0.0000
450 TRANSAMINASES INCREASED 1 0.0000
451 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
452 SOMNOLENCE 9 0.0000
453 RASH PAPULAR 1 0.0000
454 THROAT IRRITATION 2 0.0000
455 THERAPY NON-RESPONDER 2 0.0000
456 PANCREATITIS ACUTE 1 0.0000
457 CHROMATURIA 1 0.0000
458 DIZZINESS 22 0.0000
459 MUSCULAR WEAKNESS 5 0.0000
460 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
461 VISION BLURRED 6 0.0000
462 MEMORY IMPAIRMENT 6 0.0000
463 SKIN IRRITATION 2 0.0000
464 INJECTION SITE REACTION 3 0.0000
465 ADVERSE EVENT 4 0.0000
466 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
467 CHEST PAIN 8 0.0000
468 COGNITIVE DISORDER 2 0.0000
469 SLEEP DISORDER 3 0.0000
470 HYPERTENSION 9 0.0000
471 PULMONARY EMBOLISM 4 0.0000
472 ABDOMINAL DISCOMFORT 7 0.0000
473 RASH 18 0.0000
474 PRESYNCOPE 1 0.0000
475 NEURALGIA 1 0.0000
476 UNDERDOSE 3 0.0000
477 PRODUCT DOSE OMISSION ISSUE 12 0.0000
478 ALOPECIA 8 0.0000
479 HEART RATE INCREASED 4 0.0000
480 VISUAL IMPAIRMENT 5 0.0000
481 INJECTION SITE ERYTHEMA 5 0.0000
482 PNEUMONIA 13 0.0000
483 DRY EYE 2 0.0000
484 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
485 WEIGHT DECREASED 11 0.0000
486 NAUSEA 31 0.0000
487 ILLNESS 4 0.0000
488 UNRESPONSIVE TO STIMULI 1 0.0000
489 DIARRHOEA 25 0.0000
490 HAEMATOMA 1 0.0000
491 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
492 ANHEDONIA 1 0.0000
493 PLATELET COUNT DECREASED 4 0.0000
494 THROMBOSIS 3 0.0000
495 THROAT TIGHTNESS 1 0.0000
496 LIMB INJURY 1 0.0000
497 PALLOR 1 0.0000
498 TREATMENT NONCOMPLIANCE 2 0.0000
499 PRURITUS 14 0.0000
500 RESPIRATORY DISTRESS 1 0.0000
501 ANAPHYLACTIC REACTION 2 0.0000
502 PROCEDURAL PAIN 1 0.0000
503 NECK PAIN 2 0.0000
504 WEIGHT INCREASED 8 0.0000
505 RHEUMATOID ARTHRITIS 4 0.0000
506 INCORRECT DOSE ADMINISTERED 8 0.0000
507 HYPOTENSION 7 0.0000
508 EYE IRRITATION 2 0.0000
509 LIVER FUNCTION TEST ABNORMAL 1 0.0000
510 INTENTIONAL PRODUCT MISUSE 3 0.0000
511 DYSPHONIA 2 0.0000
512 CHILLS 4 0.0000
513 NASAL CONGESTION 2 0.0000
514 JOINT SWELLING 4 0.0000
515 EPILEPSY 1 0.0000
516 INJECTION SITE RASH 1 0.0000
517 DRUG ADMINISTRATION ERROR 1 0.0000
518 PERIPHERAL SWELLING 5 0.0000
519 NERVOUS SYSTEM DISORDER 1 0.0000
520 DRUG-INDUCED LIVER INJURY 1 0.0000
521 DRUG INTERACTION 5 0.0000
522 HYPOTHYROIDISM 1 0.0000
523 ARTHRALGIA 13 0.0000
524 HYPERHIDROSIS 4 0.0000
525 CHOLELITHIASIS 1 0.0000
526 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
527 VISUAL ACUITY REDUCED 1 0.0000
528 LIP SWELLING 1 0.0000
529 FUNGAL INFECTION 1 0.0000
530 SYNCOPE 3 0.0000
531 URINARY RETENTION 1 0.0000
532 GAIT INABILITY 1 0.0000
533 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
534 FLUSHING 3 0.0000
535 CHEST DISCOMFORT 3 0.0000
536 ERYTHEMA 6 0.0000
537 DEVICE USE ERROR 1 0.0000
538 HAEMORRHAGE 3 0.0000
539 HYPERKALAEMIA 1 0.0000
540 DYSPNOEA 16 0.0000
541 LYMPHADENOPATHY 1 0.0000
542 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
543 THERAPY INTERRUPTED 2 0.0000
544 CEREBRAL HAEMORRHAGE 1 0.0000
545 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
546 PAIN IN EXTREMITY 8 0.0000
547 INJECTION SITE MASS 1 0.0000
548 EPISTAXIS 2 0.0000
549 INTESTINAL OBSTRUCTION 1 0.0000
550 UNEVALUABLE EVENT 2 0.0000
551 CONDITION AGGRAVATED 8 0.0000
552 INJECTION SITE PAIN 8 0.0000
553 SEIZURE 3 0.0000
554 DECREASED APPETITE 6 0.0000
555 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
556 ABNORMAL BEHAVIOUR 1 0.0000
557 MALAISE 11 0.0000
558 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
559 WITHDRAWAL SYNDROME 1 0.0000
560 VOMITING 11 0.0000
561 PYREXIA 8 0.0000
562 DEVICE LEAKAGE 1 0.0000
563 SEPTIC SHOCK 1 0.0000
564 MENTAL DISORDER 1 0.0000
565 PSORIASIS 3 0.0000
566 TACHYCARDIA 2 0.0000
567 DRY SKIN 3 0.0000
568 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
569 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
570 TINNITUS 1 0.0000
571 SKIN DISCOLOURATION 1 0.0000
572 RENAL DISORDER 1 0.0000
573 PRODUCT USE ISSUE 4 0.0000
574 ASTHENIA 8 0.0000
575 PAIN 13 0.0000
576 OCULAR HYPERAEMIA 1 0.0000
577 RASH ERYTHEMATOUS 1 0.0000
578 FEELING ABNORMAL 5 0.0000
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
580 CELLULITIS 1 0.0000
581 HOSPITALISATION 3 0.0000
582 HAEMOGLOBIN DECREASED 2 0.0000
583 NERVOUSNESS 1 0.0000
584 RASH PRURITIC 1 0.0000
585 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
586 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
587 HAEMATOCHEZIA 1 0.0000
588 TREMOR 3 0.0000
589 INFLUENZA 2 0.0000
590 EYE PAIN 1 0.0000
591 URINARY TRACT INFECTION 3 0.0000
592 CONVULSION 1 0.0000
593 HERPES ZOSTER 1 0.0000
594 CATARACT 1 0.0000
595 IRRITABILITY 1 0.0000
596 THERAPEUTIC RESPONSE DECREASED 1 0.0000
597 PLEURAL EFFUSION 1 0.0000
598 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
599 OFF LABEL USE 14 0.0000
600 LOSS OF CONSCIOUSNESS 2 0.0000
601 DEVICE EXPULSION 1 0.0000
602 DEEP VEIN THROMBOSIS 1 0.0000
603 SWELLING FACE 1 0.0000
604 DEVICE DIFFICULT TO USE 1 0.0000
605 DEHYDRATION 2 0.0000
606 COUGH 4 0.0000
607 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
608 CHRONIC KIDNEY DISEASE 1 0.0000
609 DIABETES MELLITUS 1 0.0000
610 BLOOD PRESSURE INCREASED 2 0.0000
611 DRUG DOSE OMISSION BY DEVICE 1 0.0000
612 INJECTION SITE BRUISING 1 0.0000
613 INJECTION SITE HAEMORRHAGE 1 0.0000
614 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
615 CARDIAC ARREST 1 0.0000
616 SKIN EXFOLIATION 1 0.0000
617 BALANCE DISORDER 1 0.0000
618 PRODUCT STORAGE ERROR 1 0.0000
619 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
620 DRUG WITHDRAWAL SYNDROME 1 0.0000
621 ADVERSE DRUG REACTION 1 0.0000
622 NO ADVERSE EVENT 2 0.0000
623 SUICIDAL IDEATION 1 0.0000
624 OROPHARYNGEAL PAIN 1 0.0000
625 BREAST CANCER 1 0.0000
626 BLOOD GLUCOSE INCREASED 2 0.0000
627 DYSPHAGIA 1 0.0000
628 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
629 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
630 OVERDOSE 2 0.0000
631 SEPSIS 1 0.0000
632 DISEASE PROGRESSION 1 0.0000
633 EMOTIONAL DISTRESS 1 0.0000
634 RENAL FAILURE 1 0.0000
635 NEUTROPENIA 1 0.0000
636 DRUG INEFFECTIVE 9 0.0000
637 DRUG DEPENDENCE 1 0.0000
638 DRUG DOSE OMISSION 1 0.0000
639 CEREBROVASCULAR ACCIDENT 1 0.0000
640 MYALGIA 1 0.0000
641 ANAEMIA 1 0.0000
642 FALL 1 0.0000
643 DEATH 2 0.0000